Emerging BioTalk
  • Home
  • About Us
  • Contact
  • Search
  • Menu

Identifying What’s Important for CDMO Selection – November 17 2021

November 9, 2021/in Webinar /by Jessica Hogan

Click HERE to register for a LIVE presentation from industry expert Richard Richieri on “The Difficult Decision – What’s Important for CDMO Selection”. Abstract includes:

“Bringing your molecule candidate into next stages might be a daunting task, Therefore, finding a good strategic partner of Contract Development Manufacturing Organization (CDMO) is very important to ensure the delivery of high quality product to the clinics. Through this presentation, our speaker will give more details/insight on the best strategy to select CDMO that would suit your requirement and needs.”

Click HERE to register.

  • Author
  • Recent Posts
Richard Richieri
Chief Operating Officer at Avid Bioservices
Mr. Richieri has extensive experience in CGMP manufacturing, process development and project management in the biotech industry. He has spent over 25 years designing, developing and optimizing manufacturing processes for biologic drugs. He received his Bachelor’s degree in Chemical Engineering from the University of California, Los Angeles (UCLA) and his Master’s Degree in Chemical Engineering from the University of California, San Diego (UCSD). As part of his Master’s program, he studied how modifications to the cell cycle can improve monoclonal antibody production; an expertise that served him well when he began his industry career working at Xoma manufacturing antibodies for clinical trials using microbial and mammalian cell-based processes.
In 1996, he joined Peregrine Pharmaceuticals and worked on process engineering for each one of the company’s clinical antibody programs. In 2002, Peregrine launched Avid Bioservices, a contract manufacturing subsidiary. During Avid’s formative years, Mr. Richieri, as Senior Vice President of Bioprocess Development and Manufacturing, was responsible for attracting many new clients to utilize the company’s contract development and manufacturing services. He provided oversight in all aspects of the development and production process for both American and European clients dealing with FDA and EMA directives regarding manufacturing compliance. During his tenure, Mr. Richieri also helped Avid diversify its production capabilities to include several large stainless steel bioreactor units, as well as the more agile single use disposable units. He led comparative studies to evaluate the system performance of both types of bioreactors and presented these results at major conferences as case studies, making Mr. Richieri a recognized authority on disposable manufacturing and cost-effective biologics production. Since 2011, Mr. Richieri has been acting as a consultant to the pharmaceutical industry, including being named as a Samsung Global Advisor for their biosimilar program and as acting head of the Pilot Plant biologics production at Syngene International.
Latest posts by Richard Richieri (see all)
    0
    Share this entry
    • Share on Facebook
    • Share on Twitter
    • Share on LinkedIn
    • Share by Mail
    http://emergingbiotalk.com/wp-content/uploads/2021/10/speaker-spotlight-blog-banner.png 650 1200 Jessica Hogan http://emergingbiotalk.com/wp-content/uploads/2020/05/emergingbiotalk-header.png Jessica Hogan2021-11-09 07:54:532021-11-09 07:54:53Identifying What's Important for CDMO Selection - November 17 2021

    Biotech Resource Hub >>

    • SUBSCRIBE TO OUR BLOG
    • SUBMIT YOUR BLOG POST

    Latest News

    • 5 Minutes could win you $275,000 in products and services!January 30, 2023 - 8:50 am
    • Upcoming Seminar in India: Fast track through regulatory challengesFebruary 6, 2023 - 1:10 pm
    • Enter for a chance to win $275,000 in products and services!January 9, 2023 - 11:14 am

    Categories

    • Bioprocessing
    • Biosafety Testing
    • End-to-End Solutions
    • Frontpage Article
    • Gene Therapy
    • Investigator's Brochure
    • News
    • Uncategorized
    • Vaccines
    • Viral Vectors
    • Webinar

    Archives

    • February 2023
    • January 2023
    • December 2022
    • November 2022
    • October 2022
    • September 2022
    • August 2022
    • July 2022
    • May 2022
    • April 2022
    • March 2022
    • February 2022
    • January 2022
    • November 2021
    • October 2021
    • September 2021
    • August 2021
    • July 2021
    • June 2021
    • May 2021
    • April 2021
    • March 2021
    • February 2021
    • January 2021
    • December 2020
    • November 2020
    • October 2020
    • September 2020
    • August 2020
    • July 2020
    • May 2020
    • April 2020
    • SUBSCRIBE TO OUR BLOG
    • SUBMIT YOUR BLOG POST

    Latest News

    • 5 Minutes could win you $275,000 in products and services!January 30, 2023 - 8:50 am
    • Upcoming Seminar in India: Fast track through regulatory challengesFebruary 6, 2023 - 1:10 pm
    • Enter for a chance to win $275,000 in products and services!January 9, 2023 - 11:14 am

    Categories

    • Bioprocessing
    • Biosafety Testing
    • End-to-End Solutions
    • Frontpage Article
    • Gene Therapy
    • Investigator's Brochure
    • News
    • Uncategorized
    • Vaccines
    • Viral Vectors
    • Webinar

    Archives

    • February 2023
    • January 2023
    • December 2022
    • November 2022
    • October 2022
    • September 2022
    • August 2022
    • July 2022
    • May 2022
    • April 2022
    • March 2022
    • February 2022
    • January 2022
    • November 2021
    • October 2021
    • September 2021
    • August 2021
    • July 2021
    • June 2021
    • May 2021
    • April 2021
    • March 2021
    • February 2021
    • January 2021
    • December 2020
    • November 2020
    • October 2020
    • September 2020
    • August 2020
    • July 2020
    • May 2020
    • April 2020

    Tags

    applications bioprocessing biotech blazar Congratulations Content education Europe FDA Format gene therapy grant grants Investigator's Brochure molecule new NGS Pharmaceuticals program services symposia tags things Tone VAR2 viral assurance viral clearance virus virus detection winner

    Business Hours

    Our support Hotline is available 24 Hours a day: (555) 343 456 7891

    • Monday-Friday: 9am to 5pm
    • Saturday: 10am to 2pm
    • Sunday: Closed

    Latest News

    • 5 Minutes could win you $275,000 in products and services!January 30, 2023 - 8:50 am
    • Upcoming Seminar in India: Fast track through regulatory challengesFebruary 6, 2023 - 1:10 pm
    • Enter for a chance to win $275,000 in products and services!January 9, 2023 - 11:14 am
    • The Future of BiopharmaDecember 6, 2022 - 4:39 am
    • Last chance: 3rd Annual Startup Symposium – Day 3November 10, 2022 - 5:39 am
    • The Lack of Funding for Women Entrepreneurs Doesn’t Stop Them from Launching – But We Still Have a Long Way to Go – And We Can Help Each Other. Assurea is ROOTING FOR YOU!October 21, 2022 - 8:27 am

    Categories

    • Bioprocessing
    • Biosafety Testing
    • End-to-End Solutions
    • Frontpage Article
    • Gene Therapy
    • Investigator's Brochure
    • News
    • Uncategorized
    • Vaccines
    • Viral Vectors
    • Webinar
    • Author
    • Recent Posts
    Richard Richieri
    Chief Operating Officer at Avid Bioservices
    Mr. Richieri has extensive experience in CGMP manufacturing, process development and project management in the biotech industry. He has spent over 25 years designing, developing and optimizing manufacturing processes for biologic drugs. He received his Bachelor’s degree in Chemical Engineering from the University of California, Los Angeles (UCLA) and his Master’s Degree in Chemical Engineering from the University of California, San Diego (UCSD). As part of his Master’s program, he studied how modifications to the cell cycle can improve monoclonal antibody production; an expertise that served him well when he began his industry career working at Xoma manufacturing antibodies for clinical trials using microbial and mammalian cell-based processes.
    In 1996, he joined Peregrine Pharmaceuticals and worked on process engineering for each one of the company’s clinical antibody programs. In 2002, Peregrine launched Avid Bioservices, a contract manufacturing subsidiary. During Avid’s formative years, Mr. Richieri, as Senior Vice President of Bioprocess Development and Manufacturing, was responsible for attracting many new clients to utilize the company’s contract development and manufacturing services. He provided oversight in all aspects of the development and production process for both American and European clients dealing with FDA and EMA directives regarding manufacturing compliance. During his tenure, Mr. Richieri also helped Avid diversify its production capabilities to include several large stainless steel bioreactor units, as well as the more agile single use disposable units. He led comparative studies to evaluate the system performance of both types of bioreactors and presented these results at major conferences as case studies, making Mr. Richieri a recognized authority on disposable manufacturing and cost-effective biologics production. Since 2011, Mr. Richieri has been acting as a consultant to the pharmaceutical industry, including being named as a Samsung Global Advisor for their biosimilar program and as acting head of the Pilot Plant biologics production at Syngene International.
    Latest posts by Richard Richieri (see all)
      0
      © 2020 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved. | Privacy Policy | Cookie Settings
      Strategies for GMP Implementation of Continuous Biomanufacturing – November... The Role of the Virus-Like Particle Vaccine Technology in the Evolving Pandemic...
      Scroll to top

      This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. We use cookies in our website to give you the most relevant experience. By clicking or navigating the site, you are accepting the use of all our cookies according to our Cookie Policy / Privacy Statement. You are free to decide in the Cookie Settings which categories you would like to allow. Please note that depending on what you select, the full functionality of the website may no longer be available. You may review and change your choices at any time. Further information can be found in our Privacy Policy

      Accept All CookiesCookie Settings

      Cookie and Privacy Settings



      Cookie Preferences

      When you visit our website, we store cookies on your browser to collect information. The information collected might relate to you, your preferences or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. However, you can choose not to allow certain types of cookies, which may impact your experience of the site and the services we are able to offer. Click on the different category headings to find out more and change our default settings according to your preference. You cannot opt-out of our First Party Strictly Necessary Cookies as they are deployed in order to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For more information about how we use and share your data, please follow this link.
      Privacy Statement

      Necessary

      Always Active
      These cookies are necessary for the website to operate. Our website cannot function without these cookies and they can only be disabled by changing your browser preferences.

      Functional

      These cookies enable the provision of advanced functionalities and are used for personalization. The cookies are set in particular in response to your actions and depend on your specific service requests (e.g., pop-up notification choices).Changes will take effect once you reload the page.

      Targeting

      These cookies may be set to learn more about your interests and show you relevant ads on other websites. These cookies work by uniquely identifying your browser and device. By integrating these cookies, we aim to learn more about your interests and your surfing behavior and to be able to place our advertising in a targeted manner.

      Confirm My ChoicesAllow AllDisable All

      loading

      Please wait while you are redirected to the right page...

      Please share your location to continue.

      Check our help guide for more info.

      share your location